Vanguard Capital Management
TECH icon

Vanguard Capital Management’s Bio-Techne TECH Stock Holding History

Vanguard Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$743M Buy
10,250,628
+32,070
+0.3% +$2.31M 0.02% 569
2026
Q2 		$722M Buy
10,218,558
+38,849
+0.4% +$2.1M 0.02% 586
2026
Q1 		$532M Buy
+10,179,709
New +$611M 0.01% 652

Other funds holding TECH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Capital Management's TECH Position: Q3 2026 in Review

Vanguard Capital Management increased its Bio-Techne (TECH) stake by 0.31% in Q3 2026, buying an estimated $2.31M and bringing the position to 10,250,628 shares worth $743M. The position accounts for 0.02% of the portfolio, ranked #569.

Vanguard Capital Management first reported a position in TECH in Q1 2026 and has held it in 3 quarters since. 451 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Vanguard Capital Management held 10,250,628 shares of Bio-Techne worth $743M as of Q3 2026.
  • Vanguard Capital Management bought 32,070 Bio-Techne shares in Q3 2026, an estimated $2.31M.
  • Bio-Techne made up 0.02% of Vanguard Capital Management's portfolio in Q3 2026, its #569 holding.
  • Vanguard Capital Management first reported a position in Bio-Techne in Q1 2026 and has held it in 3 quarters since.
  • 451 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.